These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33452049)

  • 1. A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team.
    Scott A; Forng RY; Russ M; Dalmaso G; Hooper S; Villari P; Cannon J; Francis J; Dingle M
    PDA J Pharm Sci Technol; 2021; 75(2):207-212. PubMed ID: 33452049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool.
    Scott A; Vanbroekhoven A; Joossen C; Knutsen C; Govezensky D; Anders HJ; Cannon J; Salvas J; Dingle M; Hutchins P; Merker P; Villari P; Ramsey S; Cundell A; Navarro V; Franz-Riethdorf M
    PDA J Pharm Sci Technol; 2023; 77(1):2-9. PubMed ID: 35840344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of rapid microbiological methods for the risk assessment of controlled biopharmaceutical environments.
    Sandle T; Leavy C; Jindal H; Rhodes R
    J Appl Microbiol; 2014 Jun; 116(6):1495-505. PubMed ID: 24575809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Applications of Biofluorescent Particle Counting in Environmental Monitoring Investigations.
    Prasad A; Milling A; Hauschild J; Ruh AC; Horsch J; Weber J; Yan L; Plourde L; Claassen M; Villari P; IJzerman-Boon P; Forng RY; Henry RB; Portmann R; Shereefa S; Urwyler S; Dassu D
    PDA J Pharm Sci Technol; 2020; 74(3):318-323. PubMed ID: 31843986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring air sampling in operating theatres: can particle counting replace microbiological sampling?
    Landrin A; Bissery A; Kac G
    J Hosp Infect; 2005 Sep; 61(1):27-9. PubMed ID: 16009457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time measurements of airborne biologic particles using fluorescent particle counter to evaluate microbial contamination: results of a comparative study in an operating theater.
    Dai C; Zhang Y; Ma X; Yin M; Zheng H; Gu X; Xie S; Jia H; Zhang L; Zhang W
    Am J Infect Control; 2015 Jan; 43(1):78-81. PubMed ID: 25564128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation in interdisciplinary meetings on genetic diagnostics (NGS).
    Koole T; van Burgsteden L; Harms P; ; van Diemen CC; van Langen IM
    Eur J Hum Genet; 2017 Oct; 25(10):1099-1105. PubMed ID: 28832563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virtual team group process.
    Bell M; Robertson D; Weeks M; Yu D
    Can J Nurs Leadersh; 2002; 15(3):30-3. PubMed ID: 12395975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group evaluation: a collaborative, peer-mediated behavior management system.
    Salend SJ; Whittaker CR; Reeder E
    Except Child; 1993; 59(3):203-9. PubMed ID: 8432303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myth of the top management team.
    Katzenbach JR
    Harv Bus Rev; 1997; 75(6):82-91. PubMed ID: 10174799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submarines, spacecraft and exhaled breath.
    Pleil JD; Hansel A
    J Breath Res; 2012 Mar; 6(1):019001. PubMed ID: 22366644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water-based condensation particle counters for environmental monitoring of ultrafine particles.
    Liu W; Kaufman SL; Osmondson BL; Sem GJ; Quant FR; Oberreit DR
    J Air Waste Manag Assoc; 2006 Apr; 56(4):444-55. PubMed ID: 16681209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new coincidence model for single particle counters, Part I: Theory and experimental verification.
    Knapp JZ; Abramson LR
    J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Technology Society Report on the FDA Digital Health Software Precertification Program Meeting.
    King F; Klonoff DC; Ahn D; Adi S; Berg EG; Bian J; Chen K; Drincic A; Heyl M; Magee M; Mulvaney S; Pavlovic Y; Prahalad P; Ryan M; Sabharwal A; Shah S; Spanakis E; Thompson BM; Thompson M; Wang J
    J Diabetes Sci Technol; 2019 Jan; 13(1):128-139. PubMed ID: 30394807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The drug diagnostic co-development concept paper: commentary from the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop.
    Hinman LM; Huang SM; Hackett J; Koch WH; Love PY; Pennello G; Torres-Cabassa A; Webster C
    Pharmacogenomics J; 2006; 6(6):375-80. PubMed ID: 16652120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid On-Site Monitoring of Bacteria in Freshwater Environments Using a Portable Microfluidic Counting System.
    Yamaguchi N; Fujii Y
    Biol Pharm Bull; 2020; 43(1):87-92. PubMed ID: 31902936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies.
    Dalmaso G; Campanella A; Lazzeri P
    PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.
    Acquadro C; Berzon R; Dubois D; Leidy NK; Marquis P; Revicki D; Rothman M;
    Value Health; 2003; 6(5):522-31. PubMed ID: 14627058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.